Skip to content

Clinical trials

Terminated Phase 1/2 Colonic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Phase: Phase 1/2 Status: Terminated Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20083
20091
20102
20111
20131
20171
20181
20192
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
NextCure, Inc.2
Tokyo University2
Brown University1
Eisai Inc.1
Generic Devices Consulting, Inc.1
George Albert Fisher1
Gilead Sciences1
NantCell, Inc.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms19
Rectal Neoplasms10
Colorectal Neoplasms7
Neoplasm Metastasis7
Ovarian Neoplasms4
Stomach Neoplasms4
Gastrointestinal Neoplasms3
Lung Neoplasms3
Breast Neoplasms2
Head and Neck Neoplasms2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.